Epidemiology, diagnosis and treatment of enteric fever

Current Opinion in Infectious Diseases

Volumn 11, Issue 5, 1998, Pages 583-590

  Parry, Christopher M ^a   Beeching, Nicholas J ^b  

^a Centre for Tropical Diseases Vietnam   (Viet Nam)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFIXIME; CEFUROXIME AXETIL; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIUM CULTURE; HUMAN; PLASMID; POLYMERASE CHAIN REACTION; REVIEW; SERODIAGNOSIS; SMALL INTESTINE PERFORATION; STRAIN DIFFERENCE; TYPHOID FEVER;

EID: 0031768476     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-199810000-00010     Document Type: Review

References (70)

1. Richens J. Typhoid. Chapter 2 in Ed. Cox FEG 'The Wellcome Trust Illustrated History of Tropical Diseases', Wellcome Trust, London 1996; pp 24-39 and 411-413.
2. Pang T, Levine MM, Ivanoff B, Wain J, Finlay BB. Typhoid fever -important issues still remain. Trends Microbiol 1998; 6:131-133.
3. Mathieu JJ, Henning KJ, Bell E, Frieden TR. Typhoid fever in New York City, 1980 through 1990. pp. Arch Intern Med 1994; 154:1713-1718.
4. Zenilman JM. Typhoid fever. JAMA 1997; 278:847-850.
5. Rowe B, Ward L, Threlfall EJ. Multidrug-resistant Salmonella typhi: a worldwide epidemic. Clin Infect Dis 1997; 24 (suppl 1):S106-109. Excellent overview and summary of multidrug resistance.
6. Murdoch DA, Banatvala NA, Bone A, Shoismatulloev BI, Ward LR, Threllfall EJ. Epidemic ciprofloxacin-resistant Salmonella typhi in Tajikistan. Lancet 1998; 351:339.
7. Parry CM, Wain J, Chinh NT, Vinh H, Farrar JJ. 19??; Quinolone-resistant Salmonella typhi in Viet Nam. Lancet 1998; 351:1289.
8. Kapil A, Sood S, Reddaiah VP, Das B, Seth P. Paratyphoid fever due to Salmonella enterica serotype paratyphi A. Emerg Infect Dis 1997; 3:407.
9. Karamat KA, Mirza SH, Beeching NJ. Emergence of multiresistant Salmonella paratyphi A in Pakistan [abstract]. J Infect 1998; 36:A9.
10. Shukla S, Patel B, Chitnis DS. 100 years of the Widal test and its reappraisal in an endemic area. Indian J Med Res 1997; 105:53-57. Review with failings of Widal test in real life.
11. Saha SK, Ruhulamin M, Hanif M, Islam M, Khan WA. Interpretation of the Widal test in the diagnosis of typhoid fever in Bangladeshi children. Ann Trop Paed 1996; 16:75-78.
12. Harries AD, Kamoto O, Maher D, Mukibii J, Khoromana C. Specificity of the Widal test in healthy blood donors and patients with meningitis. J Infect 1995; 31:149-150.
13. Clegg A, Passey , Omena M, Karigifa , Suve N. Re-evaluation of the Widal agglutination test in response to the changing pattern of typhoid fever in the highlands of Papua New Guinea. Acta Tropica 1994; 57:255-263.
14. West B, Richens JE, Howard PF. Evaluation in Papua New Guinea of a urine coagglutination test and a Widal slide agglutination test for rapid diagnosis of typhoid fever. Trans Roy Soc Trop Med Hyg 1989; 83:715-717.
15. Choo KE, Oppenheimer SJ, Ismail AB, Ong KH. Rapid serodiagnosis of typhoid fever by dot enzyme immunoassay in an endemic area. Clin Infect Dis 1994; 19:172-176.
16. Choo KE, Davis TME, Ismail A, Tuan Ibrahim TA, Ghazali WNM. Comparative sensitivity and specificity of Typhidot and Typhidot-M tests in the diagnosis of enteric fever in Malysian children. Proceedings of the 3rd Asia-Pacific Symposium on Typhoid Fever and other Salmonellosis. Bali, Indonesia: Indonesian Society for Microbiology, 1997. P-20.
17. Hatta M, Chairuddin L, Smits HL. Evaluation of Salmonella typhi dipstick with detection of IgM antibodies from supect typhoid fever patients. Proceedings of the 3rd Asia-Pacific Symposium on Typhoid Fever and other Salmonellosis. BaIi, Indonesia: Indonesian Society for Microbiology, 1997. P-5.
18. Lim PL, Tam FCH, Cheong Y-M, Jegathesan M. One-step two-minute test to detect typhoid-specific antibodies based on particle separation in tubes. J Clin Microbiol 1998; 36:2271-2278.
19. Shaheen HI, Girgis NI, Rodier GR, Kamal KA. Evaluation of the response of human humoral antibodies to Salmonella typhi lipopolysaccharide in an area of endemic typhoid fever. Clin Infect Dis 1995; 21:1012-1013.
20. Chart H, Ward LR, Rowe B. Serological response of patients with clinical typhoid. Serodiagn Immunother Infect Disease 1995; 7:30-33.
21. Pandya M, Pillai P, Deb M. Rapid diagnosis of typhoid fever by detection of Barber protein and Vi antigen of Salmonella serotype Typhi. J Med Microbiol 1995; 43:185-188.
22. Gasem MH, Dolmans WMV, Isbandrio BB, Wahyono , Keuter M, Djokomoeljanto R. Culture of Salmonella typhi and Salmonella paratyphi from blood and bone marrow in suspected typhoid fever. Trop Geogr Med 1995; 47:164-167.
23. Wain J, Diep TS, Ho VA, Walsh AM, Hoa NTT, Parry CM, White NJ. Quantitation of bacteria in the blood of typhoid fever patients and relationship between counts and clinical features, transmissibility and antibiotic resistance. J Clin Microbiol 1998; 36:1683-1687. Importnat systematic study of S. Typhi microbiology in an area with epidemic multidrug resistance.
24. Bhutta ZA. Impact of age and drug resistance on mortality in typhoid fever. Arch Dis Child 1996; 75:214-217.
25. Rubin FA, McWhirter PD, Burr D, Punjabi NH, Lane E, Kumala S, Sudarmono P, Pulungsih SP, Lesmana M, Tjaniadi P, Sukri N, Hoffman SL. Rapid diagnosis of typhoid fever through identification of Salmonella typhi within 18 hours of specimen acquisition by culture of the mononuclear cell-platelet fraction of blood. J Clin Microbiol 1990; 28:825-827.
26. Gaviria-Ruiz MM, Cardona-Castro NM. Evaluation and comparison of different blood culture techniques for bacteriological isolation of Salmonella typhi and Brucella abortus. J Clin Microbiol 1995; 33:868-871.
27. Song JH, Cho H, Park MY, Na DS, Moon HB, Pai CH. Detection of Salmonella typhi in the blood of patients with typhoid fever by polymerase chain reaction. J Clin Micriobiol 1993; 31:1439-1443.
28. Hashimoto Y, Itho Y, Fujinaga Y, Khan AQ, Sultana Miyake M, Hirose K, Yamamoto H, Ezaki T. Development of nested PCR based on the ViaB sequence to detect Salmonella typhi. J Clin Microbiol 1995; 33:775-777.
29. Hoa NTT, Diep TS, Wain J, Parry CM, Hien TT, Smith MD, Walsh AL, White NJ. Community acquired septicaemia in southern Vietnam; the importance of multidrug-resistant Salmonella typhi. Trans Roy Soc Trop Med Hyg 1998; 92:(in press).
30. Mirza SH, Beeching NJ, Hart CA. The prevalence and clinical features of multi-drug resistant Salmonella typhi infections in Baluchistan, Pakistan. Ann Trop Med Parasitol 1995; 89:515-519.
31. Mirza SH, Beeching NJ, Hart CA. Multidrug resistant typhoid: a global problem. J Med Microbiol 1996; 44:317-319.
32. Jesudason MV, John R, John TJ. The concurrent prevalence of chloramphenicol-sensitive and multidrug-resistant Salmonella typhi in Vellore, S. India. Epidemiol Infect 1996; 116:225-227.
33. Karamat KA, Butt T, Hannan A, Nasir-ul-Islam S, Hussain T, Qureshi AH, Qamar RH. Problem of multidrug-resistant typhoid fever in Rawalpindi/Islamabad area. Pak Armed Forces Med J 1996; 46:48-54.
34. Saha SK, Saha S, Ruhulamin M, Hanif M, Islam M. Decreasing trend of multiresistant Salmonella typhi in Bangladesh. J Antimicrob Chemother 1997; 39:554-556. Letter reporting fall in prevalence of multidrug resistant strains in Bangladesh. More important for showing that hospital-based studies overestimate the prevalence of multidrug resistance compared to community-based studies.
35. Isbandrio BB, Gasem MH, Dolmans WMV, Hoogkamp-Korstanje JAA. Comparative activities of three quinolones and seven comparison standard drugs against Salmonella typhi from Indonesia. J Antimicrob Chemother 1994; 33:1055-1056.
36. Fica AE, Prat-Miranda S, Fernandez-Ricci A, D'Ottone K, Cabello FC. Epidemic typhoid in Chile: analysis by molecular and conventional methods of Salmonella typhi diversity in epidemic (1977 and 1981) and non epidemic (1990) years. J Clin Microbiol 1996; 34:1701-1707.
37. Thong K-L, Nair S, Chaudhry R, Seth P, Kapil A, Kumar D, Kapoor H, Puthucheary S, Pang T. Molecular analysis of Salmonella paratyphi A from an outbreak in New Delhi, India. Emerg Infect Dis 1998; 4:[http: // www.cdc.gov/hcidod/EID/vol4no3/letters.htm]. First examination of epidemic S. paratyphi A by molecular techniques.
38. Hermans PWM, Saha SK, van Leeuwen WJ, Verbrugh HA, van Belkum A, Goessens WHF. Molecular typing of Salmonella typhi strains from Dhaka (Bangladesh) and development of DNA probes identifying plasmid-encoded multidrug-resistant isolates. J Clin Microbiol 1996; 34:1373-1379.
39. Shanahan PMA, Jesudason MV, Thomson CJ, Amyes SGB. Molecular analysis of and identification of antibiotic resistance genes in clinical isolates of Salmonella typhi from India. J Clin Microbiol 1998; 36:1595-1600. Important report using a variety of molecular techniques to confirm epidemiological surveillance suggesting an epidemic of multidrug resistant S. typhi in one area superimposed on background endemicity. Also identifies genes coding for resistance to first line therapies.
40. White NJ, Parry CM. The treatment of typhoid fever. Curr Opin Infect Dis 1996; 9:298-302.
41. Rowe B, Ward LR, Threlfall EJ. Ciprofloxacin-resistant Salmonella typhi in the UK. Lancet 1995; 346:1302.
42. Jesudason MV, Malathy B, John TJ. Trend of increasing levels of minimum inhibitory concentration of ciprofloxacin to Salmonella typhi. Indian J Med Res 1996; 103:247-249.
43. Brown JC, Shanhan PMA, Jesudason MV, Thomson CJ, Amyes SGB. Mutations responsible for reduced susceptibility to 4-quinolones in clinical isolates of multi-resistant Salmonella typhi in India. J Antimicrob Chemother 1996; 37:891-900.
44. Wain J, Hoa NTT, Chinh NT, Vinh H, Everett MJ, Diep TS, Day NPJ, Solomon T, White NJ, Piddock LJV, Parry CM. Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment. Clin Infect Dis 1997; 25:1404-1410. Molecular basis for fluoroquinolone resistance; illustrates clinical importance of this, and utility of screening for nalidixic acid resistance as simple marker.
45. Ling JM, Zhou GM, Woo THS, French GL. Antimicrobial susceptibilities and β-lactamase production of Hong Kong isolates of gastroenteric salmonellae and Salmonella typhi. J Antimicrob Chemother 1991; 28:877-885.
46. Brown NM, Millar MR, Frost JA, Rowe B. Ciprofloxacin resitance in Salmonella paratyphi A. J Antimicrob Chemother 1994; 33:1258-1259.
47. Bhutta ZA. Quinolone-resistant Salmonella paratyphi B meningitis in a newborn. A case report. J Infect 1998; 36:308-310.
48. Unal S, Hayronn M, Tuncer S, Gur D, Uzun O, Akova M, Akalin . Treatment of eneteric fever with pefloxacin for 7 days versus 5 days: a randomized clinical trial. Antimicrob Agents Chemother 1996; 40:2898-2900.
49. Chinh NT, Solomon T, Thong MX, Ly NT, Hoa NTT, Wain J, Diep TS, Smith MD, Day NPJ, Phi LT, Parry CM, White NJ. Short course ofloxacin for the treatment of enteric fever. Trans Roy Soc Trop Med Hyg 1996; 91:347-349.
50. Koul P, Wani JI, Wahid A. Ciprofloxacin for multiresistant enteric fever in pregnancy. Lancet 1995; 346:307-308.
51. Leung D, Venkatesan P, Boswell T, Innes JA, Wood MJ. Treatment of typhoid in pregnancy. Lancet 1995; 346:648.
52. Bhutta ZA. Therapeutic aspects of typhoidal salmonellosis in childhood: the Karachi exeperience. Ann Trop Paed 1996; 16:299-306.
53. Girgis NI, Tribble DR, Sultan Y, Farid Z. Short course chemotherapy with cefixime in children with multidrug-resistant Salmonella typhi septicaemia. J Trop Pediatr 1995; 41:364-365.
54. Malik MS, Iqbal I, Rabbani W. A comparative study of cefixime and chloramphenicol in children with typhoid fever. Proceedings of the 3rd Asia-Pacific Symposium on Typhoid Fever and other Salmonellosis. Bali, Indonesia: Indonesian Society for Microbiology, 1997. T-4.
55. Phuong CXT, Kneen R, Mai TT, Diep PA, Ha NTT, Thuy PTT. Ann NT, Thuy TT, Luat TD, Bethell DB, Day NPJ, Wain J, White NJ, Parry CM. Comparative study of cefixime and ofloxacin for the treatment of uncomplicated typhoid fever in Vietnamese children. Proceedings of the 3rd Asia-Pacific Symposium on Typhoid Fever and other Salmonellosis. Bali, Indonesia: Indonesian Society for Microbiology, 1997. T-6.
56. Mathur YC, Mathur NC, Lal HM. Clinical efficacy of Cefuroxime axetil in S.typhi. Indian Pediatrics 1996; 33:1033-1037.
57. Wallace MR, Yousif AA, Habib HF, Tribble DR. Azithromycin and typhoid. Lancet 1994; 343:1497-1498.
58. Tribble D, Girgis N, Habib N, Butler T. Efficacy of azithromycin for typhoid fever. Clin Infect Dis 1995; 21:10465-1046.
59. Girgis Nl, Brown FM, Butler T, Tribble D. Randomised trial of azithromycin vs ciprofloxacin for treatment of typhoid fever. Proceedings of the 7th International Conference for Infectious Diseases. Hong Kong, 1996. 12.001.
60. Butler T, Sridhar C, Daga M, Jani, Pandit R, Khakhria R, Potkar C, Johnson R. Azithromycin vs chloramphenoicol in the treatment of typhoid fever in India. Abstracts of the 37th Interscience Conference on Antimicrobial Agenets and Chemotherapy. Toronto, Canada, 1997. LM-18.
61. Ly NT, Chinh NT, Parry CM, Diep TS, Wain NJ, White NJ. Randomised trial of azithromycin versus ofloxacin for the treatment of typhoid fever in adults. Proceedings of the 3rd Asia-Pacific Symposium on Typhoid Fever and other Salmonellosis. Bali, Indonesia: Indonesian Society for Microbiology, 1997. T-7.
62. van Basten JP, Stockenbrugger R. Typhoid perforation: a review of the literature since 1960. Trop Geogr Med 1994; 46:336-339.
63. Gupta V, Gupta SK, Shukla VK, Gupta S. Perforated typhoid enteritis in children. Postgrad Med J 1994; 70:19-22.
64. Pal DK. Evaluation of best surgical procedures in typhoid perforation -an experience of 60 cases. Trop Doct 1998; 28:16-18.
65. Tovey FI. Typhoid enteric perforation. Trop Doct 1998; 28:1-3.
66. Singh S, Singh K, Grover AS, Singh G, Gupta DK. Two-layer closure of typhoid ileal perforation: A prospective study of 46 cases. Br J Surg 1995; 82:1253.
67. Akgun Y, Bac B, Boylu S, Aban N, Tacyildiz I. Typhoid enteric perforation. Br J Surg 1995; 82:1512-1515.
68. Ameh EA, Dogo PM, Attah MM, Nmadu PT. Comparison of three operations for typhoid perforation. Br J Surg 1997; 84:558-559.
69. Kollaritsch H, Que JU, Kunz C, Wiedermann G, Herzog C, Cryz SJJr. Safety and immunogenicity of live oral cholera and typhoid vaccines administered alone or in combination with antimalarial drugs, oral polio vaccine, or yellow fever vaccine. J Infect Dis 1997; 175:871-875.
70. Engels EA, Falagas ME, Lau J, Bennish ML. Typhoid fever vaccines: a meta-analysis of studies on efficacy and toxicity. Brit Med J 1998; 316:110-116. Useful meta-analysis and review of historical studies on typhoid vaccination.